These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25369565)

  • 1. Acyclic cucurbit[n]uril-type molecular containers: influence of aromatic walls on their function as solubilizing excipients for insoluble drugs.
    Zhang B; Isaacs L
    J Med Chem; 2014 Nov; 57(22):9554-63. PubMed ID: 25369565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyclic Cucurbit[n]uril-Type Molecular Containers: Influence of Linker Length on Their Function as Solubilizing Agents.
    Sigwalt D; Moncelet D; Falcinelli S; Mandadapu V; Zavalij PY; Day A; Briken V; Isaacs L
    ChemMedChem; 2016 May; 11(9):980-9. PubMed ID: 26990780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyclic cucurbit[n]uril-type molecular containers: influence of glycoluril oligomer length on their function as solubilizing agents.
    Gilberg L; Zhang B; Zavalij PY; Sindelar V; Isaacs L
    Org Biomol Chem; 2015 Apr; 13(13):4041-50. PubMed ID: 25731639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclic CB[n]-type molecular containers: effect of solubilizing group on their function as solubilizing excipients.
    Zhang B; Zavalij PY; Isaacs L
    Org Biomol Chem; 2014 Apr; 12(15):2413-22. PubMed ID: 24595500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of a Disulfonated Derivative of Cucurbit[7]uril and Investigations of its Ability to Solubilize Insoluble Drugs.
    Robinson EL; Zavalij PY; Isaacs L
    Supramol Chem; 2015 May; 27(5-6):288-297. PubMed ID: 25937787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyclic cucurbit[n]uril molecular containers enhance the solubility and bioactivity of poorly soluble pharmaceuticals.
    Ma D; Hettiarachchi G; Nguyen D; Zhang B; Wittenberg JB; Zavalij PY; Briken V; Isaacs L
    Nat Chem; 2012 Apr; 4(6):503-10. PubMed ID: 22614387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimuli responsive systems constructed using cucurbit[n]uril-type molecular containers.
    Isaacs L
    Acc Chem Res; 2014 Jul; 47(7):2052-62. PubMed ID: 24785941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of Hydrocarbons in Aqueous Solution by Encapsulation in Acyclic Cucurbit[n]uril-Type Molecular Containers.
    Lu X; Isaacs L
    Angew Chem Int Ed Engl; 2016 Jul; 55(28):8076-80. PubMed ID: 27169688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel interaction with cucurbit [7]uril and acyclic Cucurbit[4]uril nanocontainers: A computational approach.
    Ahmadian N; Amininasab M; Mehrnejad F
    J Mol Graph Model; 2019 Jul; 90():210-218. PubMed ID: 31103913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
    Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
    Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicology and drug delivery by cucurbit[n]uril type molecular containers.
    Hettiarachchi G; Nguyen D; Wu J; Lucas D; Ma D; Isaacs L; Briken V
    PLoS One; 2010 May; 5(5):e10514. PubMed ID: 20463906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triazole functionalized acyclic cucurbit[n]uril-type receptors: host·guest recognition properties.
    Xue W; Zavalij PY; Isaacs L
    Org Biomol Chem; 2019 Jun; 17(22):5561-5569. PubMed ID: 31112196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
    Stojanov M; Nielsen HM; Larsen KL
    Int J Pharm; 2012 Jan; 422(1-2):349-55. PubMed ID: 22027391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyclic Cucurbit[n]uril-Type Containers as Receptors for Neuromuscular Blocking Agents: Structure-Binding Affinity Relationships.
    Shaya D; Isaacs L
    Croat Chem Acta; 2019 Jul; 92(2):163-171. PubMed ID: 32855560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyclic Cucurbit[n]uril-type Receptors: Preparation, Molecular Recognition Properties and Biological Applications.
    Ganapati S; Isaacs L
    Isr J Chem; 2018 Apr; 58(3-4):250-263. PubMed ID: 29805180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyclic cucurbit[n]uril molecular containers selectively solubilize single-walled carbon nanotubes in water.
    Shen C; Ma D; Meany B; Isaacs L; Wang Y
    J Am Chem Soc; 2012 May; 134(17):7254-7. PubMed ID: 22512431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyclic Cucurbit[n]uril-Type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft Tumors.
    Hettiarachchi G; Samanta SK; Falcinelli S; Zhang B; Moncelet D; Isaacs L; Briken V
    Mol Pharm; 2016 Mar; 13(3):809-18. PubMed ID: 26756920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amorphous Drug Solubility and Maximum Free Drug Concentrations in Cyclodextrin Solutions: A Quantitative Study Using NMR Diffusometry.
    Ueda K; Higashi K; Moribe K
    Mol Pharm; 2021 Jul; 18(7):2764-2776. PubMed ID: 34180226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexation of Fluorofenidone by Cucurbit[7]uril and β-Cyclodextrin: Keto-Enol Tautomerization to Enhance the Solubility.
    Ma WJ; Chen HY; Huang YL; Chen JM; Lu TB
    Mol Pharm; 2023 Sep; 20(9):4517-4527. PubMed ID: 37526016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.